What the dual diagnosis route covers
Use dual diagnosis program and MVBH admissions as general planning references for this decision. Ask MVBH to confirm any service, access, eligibility, coverage, credential, hours, outcome, treatment mode, or population-specific detail before relying on it.
MVBH describes its dual diagnosis treatment as integrated care for adults with co-occurring mental health and substance use disorders. That statement defines the verified service population and the integrated focus. It does not specify an individual assessment result.
For this route, bipolar disorder represents the mental health side of the stated framework, while stimulant use represents the substance use side. SAMHSA defines co-occurring disorders as the coexistence of a mental health disorder and a substance use disorder. Keeping both sides visible is the central decision value of this page.
The evidence does not describe assessment instruments, timing, eligibility standards, or clinical conclusions. Those details should not be assumed from the dual diagnosis label. The supported takeaway is narrower: this combination belongs within the subject boundary of co-occurring mental health and substance use concerns.